Tuesday, May 26, 2026
ADVT 
International

UK opens second ballot for Young Professional visa scheme for Indians

Darpan News Desk IANS, 25 Jul, 2023 11:42 AM
  • UK opens second ballot for Young Professional visa scheme for Indians

London, July 25 (IANS) The UK government has announced the opening of the second ballot of the Young Professional Scheme for Indian citizens between 18 to 30 years of age.

The ballot, which opened on Monday, will close at 1.30 p.m. on Thursday, the British High Commission announced in a tweet.

The scheme, formally launched this year, allows Indian citizens with a graduate or postgraduate qualification to live and work in the UK for up to two years.

It allows the candidate to enter the UK at any time while their visa is valid, and leave and come back at any time during their stay. T

here are 3,000 places available for the India Young Professionals Scheme visa in 2023.

While most places were given in the first ballot which opened in February, the remaining places will be given in the July ballot.

Successful candidates in the ballot need to apply for their visa by the deadline given in a subsequent invitation to apply, which is usually within a month's period.

Also, they must travel to the UK within six months of applying for their visa.

The application fee charges have been set at 259 pounds and additional costs involved is a 940-pound healthcare surcharge and proof that the applicant has 2,530 pounds in personal savings.

To be eligible for the Young Professionals Scheme visa one must be an Indian national or citizen between 18 and 30 years old and have 2,530 pounds in savings to support themselves in the UK.

Also applicants should not have children under the age of 18 living with them or who they are financially responsible for.

MORE International ARTICLES

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins
Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day
Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.
That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine
Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent